Literature DB >> 21117390

Insulin therapy and cancer risk in diabetes mellitus.

Julia Platts1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21117390      PMCID： PMC4952419          DOI： 10.7861/clinmedicine.10-5-509

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  16 in total

1.  Metformin and reduced risk of cancer in diabetic patients.

Authors:  Josie M M Evans; Louise A Donnelly; Alistair M Emslie-Smith; Dario R Alessi; Andrew D Morris
Journal:  BMJ       Date:  2005-04-22

2.  Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.

Authors:  Samantha L Bowker; Sumit R Majumdar; Paul Veugelers; Jeffrey A Johnson
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

3.  Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.

Authors:  P Kurtzhals; L Schäffer; A Sørensen; C Kristensen; I Jonassen; C Schmid; T Trüb
Journal:  Diabetes       Date:  2000-06       Impact factor: 9.461

Review 4.  New horizons--alternative routes for insulin therapy.

Authors:  David R Owens
Journal:  Nat Rev Drug Discov       Date:  2002-07       Impact factor: 84.694

5.  Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells.

Authors:  Doron Weinstein; Meital Simon; Einat Yehezkel; Zvi Laron; Haim Werner
Journal:  Diabetes Metab Res Rev       Date:  2009-01       Impact factor: 4.876

6.  Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study.

Authors:  L G Hemkens; U Grouven; R Bender; C Günster; S Gutschmidt; G W Selke; P T Sawicki
Journal:  Diabetologia       Date:  2009-06-30       Impact factor: 10.122

7.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

8.  Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults.

Authors:  Steven S Coughlin; Eugenia E Calle; Lauren R Teras; Jennifer Petrelli; Michael J Thun
Journal:  Am J Epidemiol       Date:  2004-06-15       Impact factor: 4.897

Review 9.  The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.

Authors:  Edward Giovannucci; Dominique Michaud
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

10.  Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin.

Authors:  Aleksey V Matveyenko; Sarah Dry; Heather I Cox; Artemis Moshtaghian; Tatyana Gurlo; Ryan Galasso; Alexandra E Butler; Peter C Butler
Journal:  Diabetes       Date:  2009-04-29       Impact factor: 9.461
View more
  2 in total

Review 1.  Anti-Diabetic Drugs: Cure or Risk Factors for Cancer?

Authors:  Jeny Laskar; Kasturi Bhattacharjee; Mahuya Sengupta; Yashmin Choudhury
Journal:  Pathol Oncol Res       Date:  2018-03-13       Impact factor: 3.201

Review 2.  Do GLP-1-based therapies increase cancer risk?

Authors:  Michael A Nauck; Nele Friedrich
Journal:  Diabetes Care       Date:  2013-08       Impact factor: 19.112
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.